Delivery Order SPE2DB22D1106-SPE2DB24FEBH4
Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,172.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,808,700 units of the medication Ketorolac 60 mg/2 ml vial. The contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,020.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,476,985 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial. The contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $2,530.98 to provide 4564108769 ketorolac 30 mg/ml vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,502,885 units of Ketorolac 60 mg/2 ml vials. The total ceiling value of the contract is $1,591.70 with a completion date of June 11, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is for the supply of 4,563,483,681 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial, 2 ml, with a potential value of $5,244.73 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp also holds an...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KETOROLAC 60 MG/2 ML VIAL 2ML. The contract has a potential value of $1,931.50 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,380.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KETOROLAC 60 MG/2 ML VIAL 2ML. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to military treatment...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 60 mg/2 ml vial (2 ml). The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price of $1,164.06 and a completion date of June 16, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp is the prime contractor and there are no noted subcontractors. This contract is...
- This is a $1,124.88 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 30 mg/mL ketorolac vials. The contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This award does not have a set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.72 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a medication used for pain management. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...